FDA Clearance Tracker · P990028-S007
FOCALSEAL-L SYNTHETIC ABSORBABLE SEALANT
Last checked: Nov 20, 2026Latest source record: Dec 4, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Dec 4, 2003
Approved
Time to decision
22 days
Received Nov 12, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class II
The decision
- FDA number
- P990028-S007
- Device name
- FOCALSEAL-L SYNTHETIC ABSORBABLE SEALANT
- Applicant
- Genzyme Corp.
- Applicant location
- Cambridge, MA
- Received
- Nov 12, 2003
- Decided
- Dec 4, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P990028
Device type
- Device type
- Mesh, surgical, polymeric (FTL)
- Device class
- Class II
- Regulation
- 21 CFR 878.3300
- Specialty
- General & Plastic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR COMPLAINT RETURN AND INVESTIGATION OPERATIONS TO BE TRANSFERRED FROM THE GENZYME FACILITY IN LEXINGTON, MASSACHUSETTS TO THE GENZYME FACILITY IN FARMINGHAM, MASSACHUSETTS.
Source documents
Other decisions for Genzyme Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.